Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Benefits of Measuring Coronary Pressure in Improving Multivessel PCI at ESC Congress 2007
EBAC-Accredited Workshop Set for Sept. 3
UPPSALA, Sweden and WILMINGTON, Mass., Aug. 31 /PRNewswire/ -- Nico
Pijls, M.D., Ph.D., and Bernard de Bruyne, M.D., Ph.D., will present the
benefits of measuring coronary pressure, or Fractional Flow Reserve (FFR),
in improving the outc...
Sanofi-aventis Announces Second Quarter 2009 Results
...of the ACTIVE-A study.
In addition, the results of various studies are due to be presented shortly at medical congresses:
(European Society of Cardiology) - Barcelona, August 29 through September 2
Results of the CURRENT/OASIS-7 study, evaluating a new therapeut...
Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research
...argolis pointed out that just five days before the esc
announcement, Dr. Bernadine Healy, former director...that the scientist who first isolated and cultured esc
once said 'embryonic stem cells are not being used...ble with RSC is rapidly approaching 200, while the esc
count still sits on zero, despite the efforts of a...
Kelly Osbourne and International Health Groups Call for Improved Education on Choices and Usage of Contraception
EUROPEAN SOCIETY OF CONTRACEPTION AND REPRODUCTIVE HEALTH (ESC)
was founded in France in 1988 and is a leading medical society
in the field...uctive health care internationally. In order to
achieve its objectives, the esc
strives to harmonize the legal situation
internationally and to promote ava...
ApoA-I Data Presented at European Society of Cardiology Congress
...ts atherosclerosis cardiovascular disease," stated Dr. Jan
Johansson, Senior Vice President Medical Affairs Resverlogix. Johansson
further added, "The esc
is a well regarded scientific meeting as well as
one of the largest with an estimated 25,000 participants. We are pleased to
have presented our data t...
Landmark SYNTAX Trial Reports Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) Express2(TM) Stents or Bypass Surgery
... Media Relations Boston Scientific Corporation
Larry Neumann 508-650-8696 (office) Investor Relations Boston Scientific Corporation
On site at esc
Natacha Gassenbach (508) 250-9348 (mobile) Media Relations Boston Scientific
Geraldine Varoqui (49) 170-782-85-58 (mobile) Media Re...
With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
...L study: a step further in title Coronary Artery Disease
Hotline Title: The BEAUTIFUL study: efficacy of session title ... artery disease and left ventricular dysfunction
Hotline 31st August 2008, 11:18 - 11:31 AM session time